Health Condition 1: null- Occupational contact dermatitis (both irritant and allergic)
Conditions
Interventions
Intervention1: Halometasone monohydrate 0.05%: After baseline assessments, patients will be advised to apply commercially available Halometasone 0.05% ointment twice daily locally as a thin layer over
Sponsors
SELF
Eligibility
Inclusion criteria
Inclusion criteria: • All patients with pruritic eczematous conditions that started or aggravated for the first time after joining the present occupation will be included. The diagnosis of occupational contact dermatitis will be done based on taking detailed medical and occupational history and the presence of clinical signs and symptoms including pruritus and eczema. • Lesions over all areas, including exposed as well as covered areas, will be included unless they are solely restricted to covered areas/ groins or genitalia.
Exclusion criteria
Exclusion criteria: • The diseases excluded were infective diseases like scabies, fungal infections, bacterial infections and all noneczematous dermatoses like psoriasis and lichen planus, even if associated with itching. • Lesions solely affecting the groins, genitals or covered areas. • Patients who are already under treatment for the presenting conditions. • Patients with history of hypersensitivity to topical steroids. • Patients (including severe/extensive eczema) in need of any form of treatment that influences the healing of the lesion such as topical treatment other than trial preparation, topical radiation therapy, systemic medication with antibiotics, antimicrobials, antihistaminics, cytostatics, corticosteroids, or ACTH will also be excluded. • Pregnant and nursing women, patients with history of cardiovascular, hematological, pancreatic, metabolic, neurological, or clinically significant laboratory abnormalities which would interfere with patient participation in the study or evaluation of patientâ??s response to therapy were excluded from screening.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| SCORAD (SCORing Atopic Dermatitis) IndexTimepoint: At 2 weeks and 4 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| â?¢IGA (Investigatorâ??s Global Assessment) scale â?¢POEM (Patient Oriented Eczema Measure) â?¢DQLI (Dermatology Life Quality Index)Timepoint: At 2 weeks and 4 weeks | — |
Countries
India
Contacts
Public ContactRITUPARNA MAITI
AIIMS, Bhubaneswar
Outcome results
None listed